Şunu aradınız:: dipeptidyl (Maltaca - İngilizce)

impedituri dipeptidyl peptidase (dpp- 4), kodiċi atc:
dipeptidyl peptidase 4 (dpp-4) inhibitors, atc code:

is-sitagliptina hija inibitur dipeptidyl peptidase -4 (dpp 4).
sitagliptin is a dipeptidyl-peptidase-4 (dpp 4) inhibitor.

alogliptin huwa inibitur ta’ dipeptidyl-peptidase-4 (dpp 4).
alogliptin is a dipeptidyl-peptidase-4 (dpp 4) inhibitor.

inibitur ta’ dipeptidyl peptidase-4 (dpp4), kodiċi atc: a10bh03
dipeptidyl peptidase 4 (dpp4) inhibitors, atc code: a10bh03

lixisenatide ma ġiex studjat flimkien ma’ inibituri ta’ dipeptidyl peptidase 4 (dpp-4) .
lixisenatide has not been studied in combination with dipeptidyl peptidase 4 (dpp-4) inhibitors.

barra minn hekk, reazzjonijiet tal-ġilda li titqaxxar huma magħrufa għall inibituri dipeptidyl peptidase-4 (dpp4) .
furthermore, exfoliative skin reactions are known for dipeptidyl peptidase-4 (dpp4) inhibitors.

is- sustanza attiva f' tesavel, sitagliptin, hija inibitur tat- tip dipeptidyl peptidase 4 (dpp4).
the active substance in tesavel, sitagliptin, is a dipeptidyl peptidase 4 (dpp-4) inhibitor.

alogliptin jappartjeni għal grupp ta’ mediċini li jissejħu impedituri dpp-4 (impedituri ta’ dipeptidyl peptidase-4).
alogliptin belongs to a group of medicines called dpp-4 inhibitors (dipeptidyl peptidase-4 inhibitors).

kategorija farmakoterapewtika: mediċini li jintużaw fid-dijabete, impedituri dipeptidyl peptidase (dpp-4), kodiċi atc: a10bh02
pharmacotherapeutic group: drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors, atc code: a10bh02

sitagliptin sitagliptin phosphate huwa impeditur attiv li jittieħed mill- ħalq, qawwi, ferm selettiv ta ’ l- enzim dipeptidyl peptidase 4 (dpp- 4) għall- kura ta ’ dijabete tip 2.
sitagliptin sitagliptin phosphate is an orally-active, potent, and highly selective inhibitor of the dipeptidyl peptidase 4 (dpp-4) enzyme for the treatment of type 2 diabetes.